202 related articles for article (PubMed ID: 29079187)
1. Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway.
Huang J; Zheng C; Shao J; Chen L; Liu X; Shao J
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):542-549. PubMed ID: 29079187
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of FOXP1 Inhibits Cell Proliferation in Hepatocellular Carcinoma by Inducing G1/S Phase Cell Cycle Arrest.
Wang X; Sun J; Cui M; Zhao F; Ge C; Chen T; Yao M; Li J
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618020
[TBL] [Abstract][Full Text] [Related]
3. [Eukaryotic translation elongation factor 1A1 positively regulates NOB1 expression to promote invasion and metastasis of hepatocellular carcinoma cells
Zhang W; Xiang M; Zheng C; Chen L; Ge J; Yan C; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1195-1202. PubMed ID: 30377124
[TBL] [Abstract][Full Text] [Related]
4. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
[TBL] [Abstract][Full Text] [Related]
6. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of wild-type RASSF1A gene expression on proliferation of hepatocellular carcinoma QGY-7703 cells].
Rui L; Xue WJ; Li P; Wang ZW; Wang P; Li HX
Ai Zheng; 2008 Sep; 27(9):924-8. PubMed ID: 18799029
[TBL] [Abstract][Full Text] [Related]
8. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.
Hong M; Almutairi MM; Li S; Li J
Phytomedicine; 2020 Mar; 68():153174. PubMed ID: 31991293
[TBL] [Abstract][Full Text] [Related]
9. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH
Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458
[TBL] [Abstract][Full Text] [Related]
10. CDCA7L promotes hepatocellular carcinoma progression by regulating the cell cycle.
Tian Y; Huang C; Zhang H; Ni Q; Han S; Wang D; Han Z; Li X
Int J Oncol; 2013 Dec; 43(6):2082-90. PubMed ID: 24141559
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs.
Farra R; Scaggiante B; Guerra C; Pozzato G; Grassi M; Zanconati F; Perrone F; Ferrari C; Trotta F; Grassi G; Dapas B
Int J Pharm; 2017 Jun; 525(2):367-376. PubMed ID: 28229942
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY
Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma-related cyclin D1 is selectively regulated by autophagy degradation system.
Wu SY; Lan SH; Wu SR; Chiu YC; Lin XZ; Su IJ; Tsai TF; Yen CJ; Lu TH; Liang FW; Li CY; Su HJ; Su CL; Liu HS
Hepatology; 2018 Jul; 68(1):141-154. PubMed ID: 29328502
[TBL] [Abstract][Full Text] [Related]
14. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
Liu L; Zhang H; Shi L; Zhang W; Yuan J; Chen X; Liu J; Zhang Y; Wang Z
Oncol Rep; 2014 Oct; 32(4):1395-400. PubMed ID: 25109327
[TBL] [Abstract][Full Text] [Related]
16. Opposing roles of C/EBPα and eEF1A1 in Sp1-regulated miR-122 transcription.
Zeng C; Sang Y; Wang FY; Zhuang SM
RNA Biol; 2020 Feb; 17(2):202-210. PubMed ID: 31561740
[TBL] [Abstract][Full Text] [Related]
17. Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
Duan Y; Tian L; Gao Q; Liang L; Zhang W; Yang Y; Zheng Y; Pan E; Li S; Tang N
Oncotarget; 2016 Jul; 7(29):45863-45875. PubMed ID: 27351279
[TBL] [Abstract][Full Text] [Related]
18. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC
Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
[TBL] [Abstract][Full Text] [Related]
19. PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells.
Yang Y; Wu J; Cai J; He Z; Yuan J; Zhu X; Li Y; Li M; Guan H
Int J Cancer; 2015 Feb; 136(4):E39-50. PubMed ID: 25142862
[TBL] [Abstract][Full Text] [Related]
20. Mig-6 is down-regulated in HCC and inhibits the proliferation of HCC cells via the P-ERK/Cyclin D1 pathway.
Li Z; Qu L; Luo W; Tian Y; Zhai H; Xu K; Zhong H
Exp Mol Pathol; 2017 Jun; 102(3):492-499. PubMed ID: 28506767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]